
|Articles|August 31, 2016
Supplements and Featured Publications
- Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldost
- Volume 22
- Issue 11
eAppendix
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
3
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
4
Innovation in Long-Acting Prevention Is the Future of HIV: Antonio Urbina, MD
5














































